Trials / Completed
CompletedNCT05860439
Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias
Long-term Follow-up of Sclerotherapy of Reticular Veins and Telangiectasias
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 191 (actual)
- Sponsor
- UPECLIN HC FM Botucatu Unesp · Academic / Other
- Sex
- Female
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
A long-term follow-up cohort study of patients that were assigned in two previous studies to compare the clinical results of sclerotherapy of telangiectasias and reticular veins of lower limbs using 0.2% polidocanol diluted in 70% hypertonic glucose (PDHG) vs 75% hypertonic glucose (HG) alone. All women, previously treated as aforementioned, were invited to be reevaluated regarding late maintenance and pigmentation over two years of follow-up. No new treatments were applied to the cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG) | Patients previously treated were reassessed for long-term follow-up. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2023-05-01
- Completion
- 2023-06-01
- First posted
- 2023-05-16
- Last updated
- 2023-10-18
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05860439. Inclusion in this directory is not an endorsement.